Events

Dementias 2026

dementias2026
Roche Diagnostics at Dementias 2026

The Dementias Conference is a leading global forum dedicated to advancing understanding, research and innovation across the full spectrum of dementia and neurodegenerative diseases. It brings together international experts, clinicians, researchers and industry leaders to share the latest scientific insights, explore emerging solutions and connect with peers from around the world.

At the upcoming conference, Roche is pleased to invite you to join us live from 25–26 February 2026. We look forward to welcoming you to our engaging programme, designed to foster meaningful discussion and collaboration. Together, we aim to deepen understanding of dementia diagnosis as a critical first step towards earlier intervention, improved care pathways and better outcomes for patients. 

We look forward to welcoming you to the Roche presence and activities at the Dementias Conference 2026.

Neurology

Alzheimer's Disease

Roche Symposium

Wednesday, 25th February 2026,
14:45 GMT 

 

The power of knowing, a conversation with Peter Berry

Join Ashton Harper from Roche Diagnostics as he speaks with Peter Berry and his friend Deb Bunt about Peter's personal journey from uncertainty to an Alzheimer’s diagnosis.

This session will highlight the crucial clinical and personal impact of an earlier diagnosis in Alzheimer’s disease, centered around the theme of "the power of knowing."

What you will learn:

  • The UK context: Understand the scale, pressure, and rising demand on memory services due to an ageing population and increasing dementia prevalence.
  • The challenge of uncertainty: Explore the difficulties clinicians face in diagnosing subtle early cognitive symptoms, and how this uncertainty affects key decisions, patient anxiety, and strain on the UK health system.
  • Roche's commitment: Discover how Roche Diagnostics is enabling clinicians with innovation, including CSF biomarker testing, the pTau181 rule-out blood test, and emerging innovations like pTau217, all designed to improve diagnostic confidence earlier in the pathway.
  • A lived experience: Hear first-hand from Peter Berry on what it was like living with diagnostic uncertainty and how receiving a diagnosis gave him a renewed sense of clarity and purpose.

Don't miss out on this exciting symposium to gain a deeper understanding of the diagnostic pathway and the human impact of earlier diagnosis. We look forward to seeing you there.